Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCFA Supplementation for GI Toxicity in Abdominopelvic Radiotherapy
NCT04700527Phase 2Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Dec 2023
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute radiation syndrome (ARS) (2 arms), sponsored by UNC Lineberger Comprehensive Cancer Center. Primary endpoint: Rate and severity of patient reported and physician determined toxicities at 3 months. Started Dec 2023; status: recruiting.
02
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT04700527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700527.